Professor of Anesthesiology/Critical Care Medicine; Sr. Associate Dean of Faculty
Johns Hopkins University School of Medicine
Baltimore, Maryland
Nauder Faraday, MD MPH. Dr. Faraday is Professor of Anesthesiology/Critical Care Medicine, Surgery, and Medicine in the JHU School of Medicine, and Professor of Epidemiology at the JHU Bloomberg School of Public. He has conducted cardiovascular research for more than 30 years, serving continuously as PI, Co-PI, Co-I, and mentor on grants from the NIH, National Science Foundation, Maryland TEDCO, American Heart Association, Anesthesia Societies, and industry sponsors. His research has involved numerous techniques, including in vitro laboratory assays, animal disease models, multi-omics association studies (GWAS, exome chip, and whole genome sequencing approaches), clinical trials, and clinical predictive analytics derived from statistical and machine learning approaches. His research has focused on identifying novel determinants of adverse outcomes after surgery, including myocardial injury, kidney injury, infection, and bleeding, using observational trial designs. More recently, he has conducted studies to improve prediction of hospital readmissions in patients with congestive heart failure, deploying machine learning on the high density physiologic and clinical data inputs from the Electronic Health Record. As PI and Co-I, he has participated in and published results from numerous multi-disciplinary research projects involving scientists with expertise in medicine/biology, statistics, genetics, data science, and engineering. His research expertise in vascular thrombotic diseases (e.g. coronary heart disease, stroke) is complemented by his clinical expertise in cardiovascular anesthesia and critical care medicine, environments in which he continues to practice clinical medicine.
XAU - Perioperative Management of Cardiac Patients
Wednesday, September 17, 2025
10:00 AM - 11:00 AM EDT
Disclosure(s): Abbvie: Stock-publicly held company (excluding mutual/index funds) (Ongoing); Amgen: Stock-publicly held company (excluding mutual/index funds) (Ongoing); Eli Lilly: Stock-publicly held company (excluding mutual/index funds) (Ongoing); Johnson & Johnson: Stock-publicly held company (excluding mutual/index funds) (Ongoing); Medtronic: Stock-publicly held company (excluding mutual/index funds) (Ongoing); Novo Nordisk: Stock-publicly held company (excluding mutual/index funds) (Ongoing); Pfizer: Stock-publicly held company (excluding mutual/index funds) (Ongoing)